down arrow

Morepen Labs.

40
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE083A01026
  • NSEID: MOREPENLAB
  • BSEID: 500288
INR
50.25
2.13 (4.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 31.04 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Morepen Labs. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
135.00
55.00
126.00
98.00
39.00
29.00
Adjustment
34.00
27.00
19.00
31.00
36.00
40.00
Changes In working Capital
-58.00
-158.00
-181.00
-78.00
-58.00
-51.00
Cash Flow after changes in Working Capital
111.00
-74.00
-35.00
52.00
16.00
17.00
Cash Flow from Operating Activities
73.00
-91.00
-60.00
50.00
11.00
17.00
Cash Flow from Investing Activities
-83.00
-46.00
-31.00
-70.00
-12.00
-13.00
Cash Flow from Financing Activities
5.00
143.00
66.00
47.00
5.00
0.00
Net Cash Inflow / Outflow
-4.00
5.00
-25.00
27.00
4.00
3.00
Opening Cash & Cash Equivalents
21.00
15.00
41.00
13.00
9.00
5.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
16.00
21.00
15.00
41.00
13.00
9.00
Compare Cash Flow Results of Morepen Labs.
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
135.42
2399.36
-2,264.00
-94.36%
Adjustment
34.2
212.2
-178.00
-83.88%
Changes In working Capital
-58.12
20.42
-78.00
-384.62%
Cash Flow after changes in Working Capital
111.49
2631.98
-2,520.00
-95.76%
Cash Flow from Operating Activities
73.37
2152.45
-2,079.00
-96.59%
Cash Flow from Investing Activities
-83.3
-2080.52
1,997.00
96.00%
Cash Flow from Financing Activities
5.2
5.27
0.00
-1.33%
Net Cash Inflow / Outflow
-4.72
77.19
-81.00
-106.11%
Opening Cash & Cash Equivalents
21.67
304.82
-283.00
-92.89%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
16.95
382.01
-366.00
-95.56%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 180.48% vs -51.34% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
73.37
-91.17
180.48%